Fri, Dec 26, 2014, 9:10 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

  • eurasiastocks eurasiastocks Apr 10, 2014 3:58 PM Flag

    France generics and Alnylam - Investors Unite, Strength in Numbers and understanding reality

    Patents on the drugs Alny is working on for commercialization will have patent protection for 20 years Therefore no need to worry about Alnylam's stock price regarding France and their generic drug options. Alny will be able to sell their RNAi drugs and make $billions for 20 Years without competition for that drug. The Generics will not be able to produce or sell Alny's drugs until the patent expires 20 years from now. Alny investors can rest assured no devaluation regardless of whatever France decides as there is no generic alternative to Alny's RNAi.

    Sentiment: Strong Buy

97.92+4.40(+4.70%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.